首页 > 市场调查报告书 > 材料

市场调查报告书

商品编码

1359941

全球褐藻醣胶市场 - 2023-2030

Global Fucoidan Market - 2023-2030

出版日期: 2023年10月11日 | 出版商:

DataM Intelligence | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述：

2022年，全球褐藻醣胶市场规模达9,050万美元，预估至2030年将达2.026亿美元，2023-2030年预测期间复合年增长率为10.6%。

由于对天然保健品和原料的需求不断增长，褐藻醣胶市场最近不断扩大。褐藻醣胶通常作为胶囊或粉末形式的补充剂用于多种食品和饮料中。岩藻依聚醣市场受到多种因素的影响，包括对有机产品的需求不断增长、健康意识的提高以及慢性病的增加。褐藻醣胶在治疗免疫失调、癌症和心血管疾病方面具有许多潜在优势。

随着製药业的发展，全球对岩藻依聚醣的需求不断增加。抗氧化剂使用的是岩藻依聚醣。它也用作抗肿瘤剂、抗血管生成剂、抗病毒剂、抗发炎剂、抗凝血剂和抗血栓剂。护肤品和化妆品产业也越来越多地使用岩藻依聚醣。它具有许多保持皮肤弹性和保水性的有利品质。

对于开发新的化妆品配方，例如抗衰老护肤品，岩藻依聚醣是目前正在研究的天然替代品。例如，2023年5月，英国公司OCEANIUM创造了高纯度生物活性成分“OCEAN ACTIVES Fucoidan”，化妆品公司可以用它来创造各种护肤配方。与此类似，Luminact Brite 和 Luminact Reverse 是由岩藻依聚醣成分供应商 Marinova 与总部位于德国的特种化学品製造商 Innospec 合作开发的化妆品成分。

动态：

不断努力改进微藻萃取和培养

营养食品和补充品市场对源自藻类的岩藻依聚醣的需求不断增加。与其他 β-葡聚醣（例如酵母来源的 β-葡聚醣）相比，藻类 β-葡聚醣更便宜。此外，几种棕色海藻主要在细胞壁基质上含有岩藻依聚醣。来自微藻的β-葡聚醣和岩藻依聚醣萃取物目前是广泛研究的主题。由于这个因素，市场正在扩大。透过提高生产能力，微藻原料供应商不断努力满足岩藻依聚醣市场客户的需求。

例如，美国生物技术公司F3 Platform Biologics 于2019 年8 月向Algatech Ltd. 授予从微藻眼虫中生产Beta-1 和Beta-3 葡聚醣的许可和权利。此外，透过开发微藻培养的萃取方法，生产商将能够在食品、膳食补充剂和医疗保健等多种行业中成功使用 β-葡聚醣微藻。许多组织正在这方面做出大量努力。预计这些因素将很快支持整个市场的扩张。

全球心血管疾病和癌症病例正在增加

在已开发国家，心臟病和中风在成人死亡人数中排名第一和第二。为了在迫切需要治疗之前帮助预防，对促进心血管健康和抑制癌细胞的膳食补充剂和营养保健品的需求增加。值得注意的是，已经证明岩藻依聚醣和β-葡聚醣可以安全有效地治疗这两种疾病。 β-葡聚醣和岩藻依聚醣有助于动员免疫细胞并启动防御反应。在癌症的情况下，这种触发的反应有助于身体计划对癌细胞的协调攻击。此外，它还有助于抑制癌细胞的生长。这些因素支持市场扩张。

生产成本高

从海藻中提取褐藻醣胶可能非常昂贵且需要大量劳动力。这可能会影响岩藻依聚醣产品的可承受性和市场渗透率。含有岩藻依聚醣的特定海藻种类可能很难找到，并且需要大量劳动力才能采集。海藻收穫需要船隻、熟练劳动力和设备。此外，富含岩藻依聚醣的海藻的获取可能因地区和季节而异。

为了确保岩藻依聚醣的品质和纯度，需要严格的品质控管程序。其中包括污染物测试，确保不含重金属或其他污染物，以及检查岩藻依聚醣的含量。此外，从海藻中提取岩藻依聚醣需要复杂且漫长的程序。这通常需要使用各种方法和溶剂进行清洁、干燥、研磨和提取岩藻依聚醣。这些过程需要熟练的劳动力和专用机械。预计这些因素将在一定程度上限制市场扩张。

Due to the rising demand for natural health products and ingredients, the fucoidan market has expanded recently. Fucoidan is commonly utilized in a range of foods and beverages often available, as supplements in the form of capsules or powders. The market for fucoidan is being influenced by factors, including the growing demand for organic products increasing health awareness and the rise, in chronic diseases. Fucoidan has a number of potential advantages in the treatment of immune disorders, cancer, and cardiovascular disease.

Global demand for fucoidan is increasing as the pharmaceutical sector grows. Antioxidant use is made of fucoidan. It is also employed as an antitumor, anti-angiogenic, antiviral, anti-inflammatory, anticoagulant, and antithrombotic agent. The skincare and cosmetics industries are also using more and more fucoidan. It has a number of advantageous qualities for maintaining skin elasticity and water retention.

For the development of new cosmetic product formulations, such as anti-aging skin care products, fucoidan is a natural alternative that is currently being researched. For instance, in May 2023, the U.K. company OCEANIUM created the high-purity bioactive ingredient 'OCEAN ACTIVES Fucoidan,' which cosmetic companies can use to create various skincare formulations. Similar to this, Luminact Brite and Luminact Reverse are cosmetic ingredients that were developed by Marinova, a supplier of fucoidan ingredients, in collaboration with Innospec, a manufacturer of specialty chemicals with headquarters in Germany.

Dynamics:

Growing Efforts to Improve Microalgae Extraction and Cultivation

The market for nutritional food and supplements is seeing an increase in demand for fucoidans derived from algae. Compared to other beta-glucans, such as yeast-derived beta-glucan, the algal beta-glucan is less expensive. Moreover, several species of brown seaweed contain fucoidan primarily on the cell wall matrix. Beta-glucan and fucoidan extracts from microalgae are currently the subject of extensive research. The market is expanding as a result of this factor. By improving their production capabilities, the suppliers of microalgae ingredients are continuously working to meet the demands of customers in the fucoidan market.

For instance, the US biotechnology company F3 Platform Biologics granted the licence and the rights to produce Beta-1 and Beta-3 glucans from the microalgae Euglena Gracilis to Algatech Ltd. in August 2019. Additionally, by developing extraction methods for microalgae cultivation, producers will be able to use beta-glucan microalgae successfully in a variety of industries, including food, dietary supplements, and healthcare. Numerous organisations are making numerous efforts in this regard. These factors are anticipated to soon support the market's expansion as a whole.

Global Cardiovascular Disease and Cancer Cases are Growing

In developed countries, heart disease and stroke are first and second in terms of adult fatalities. To help with prevention before an urgent need for a cure arises, demand for dietary supplements and nutraceuticals that boost cardiovascular health and inhibit cancer cells has increased. Notably, it has been proven that fucoidans and beta-glucans can be used to treat both diseases in a safe and effective manner. Beta-glucans and fucoidans assist in mobilising immune cells and initiating a defence response. In cases of cancer, this triggered response helps the body plan a coordinated attack on cancer cells. Additionally, it helps to restrain the growth of cancerous cells. These factors support market expansion.

High Production Costs

Fucoidan can be expensive and labor-intensive to extract from seaweed. This may have an impact on fucoidan product affordability and market penetration. The specific kinds of seaweed that contain fucoidan can be difficult to find and require a lot of labour to gather. Boats, skilled labour, and equipment are needed for seaweed harvesting. Furthermore, the accessibility of seaweed abundant in fucoidan may differ regionally and according to the season.

Strict quality control procedures are required in order to guarantee the fucoidan's quality and purity. Testing for contaminants, making sure there are no heavy metals or other pollutants, and checking the amount of fucoidan are all included in this. Moreover, complicated and drawn-out procedures are needed to extract fucoidan from seaweed. This typically entails cleaning, drying, grinding, and extracting fucoidan using a variety of methods and solvents. Both skilled labour and specialised machinery are needed for these processes. Such elements are anticipated to limit market expansion to some degree.

Segment Analysis:

The global fucoidan market is segmented based on form, functionality, application and region.

Capsule Form can be Used for Producing Pharmaceuticals and Dietary Supplements

The capsule segment leads the market. The capsule has a higher bioavailability than other forms, such as liquid, semi-liquid, or powder form. This qualifies it as an appropriate delivery method that enables the compound to be effectively delivered to the bloodstream. These attributes make the product well suited for manufacturing top notch medications for individuals dealing with conditions such, as cancer diabetes, Alzheimers disease (AD) and ailments. Furthermore several companies are introducing supplements, in format as they are easier to ingest and mask the unfavorable tastes and smells associated with their components.

Geographical Penetration:

Rising Prevalence of Health Ailments and Life-Threatening Diseases is Driving the Demand for Market in Europe

The growing demand, for compound-based pharmaceuticals in the region has been fueled by an emphasis on discovering ingredients for developing innovative medications and dietary supplements through clinical trials. The U.K. market in comparison to countries is also experiencing growth. Many startups are expanding their capabilities to process seaweed, which is expected to drive market expansion. The use of seaweed and seaweed processing in this country is growing, even though humans consume a significant amount of seaweed. Producing high-end, premium products that can be used in pharmaceuticals, cosmetics, and dietary supplements is where manufacturers focus their efforts.

COVID-19 Impact Analysis:

The COVID-19 pandemic had an impact on the availability of the raw material (brown seaweed), which is processed to further develop fucoidan. Many farmers in Europe and Asia, two of the top seaweed exporters, were unable to harvest seaweed in a timely manner, which led to the decay of the seaweed and financial loss for the concerned farmers. During the COVID-19 pandemic, its use in the pharmaceutical industry was also impacted. Some of the areas that suffered a great deal during that time were clinical trials and research. Clinical trials of new products on patients were severely hampered as hospital visits by diabetics, cancer patients, and other patients decreased out of contracting for catching COVID-19.

Russia-Ukraine War Impact Analysis:

When a supply chain depends on resources or infrastructure in areas where there is conflict, such as when harvesting seaweed or using extraction facilities or transportation routes, disruptions could happen. This could result in scarcities and higher production costs. Geopolitical tensions can affect the price of imports and exports by causing currency fluctuations. Currency devaluation in either country increased the marketability of their products, which had an impact on fucoidan prices.

By Form

Powder
Capsule
Others

By Functionality

Immunity Booster
Cardiovascular Health
Others

By Application

Food and Beverages
Supplements
Others

By Region

North America
- U.S.
- Canada
- Mexico

Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe

South America
- Brazil
- Argentina
- Rest of South America

Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific

Middle East and Africa

Key Developments

In May, 2023, a high-purity bioactive ingredient called "OCEAN ACTIVES Fucoidan" was created by the U.K. company OCEANIUM that cosmetic companies can use to create various skincare formulations.
In April, 2023, Official support for the Royal Society of Chemistry spring meeting came from Dextra Laboratories Ltd. The conference would provide funding for the ECR bursaries, enhancing the participation of young researchers.
In February, 2023, Hepatica made significant investments to build its production system in accordance with the standards set by the European Commission. The company's production, supply, and storage systems were awarded the HACCP certificate.

Competitive Landscape

The major global players in the market: KANEHIDE BIO Co., Ltd, Kamerycah, Inc., Yaizu Suisankagaku, Fucoidan Force, Seaherb, Haerim Fucoidan, Marinova, Hi-Q Marine Biotech International Ltd., Molekula Group, and Absonutrix LLC.

Why Purchase the Report?

To visualize the global fucoidan market segmentation based on form, functionality, application, and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of fucoidan market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global fucoidan market report would provide approximately 61 tables, 56 figures and 186 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Form
3.2. Snippet by Functionality
3.3. Snippet by Application
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Growing Efforts to Improve Microalgae Extraction and Cultivation
  - 4.1.1.2. Global Cardiovascular Disease and Cancer Cases are Growing
- 4.1.2. Restraints
  - 4.1.2.1. High Production Costs
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 7.1.2. Market Attractiveness Index, By Type
7.2. Powder*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Capsule
7.4. Others

8. By Functionality

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
- 8.1.2. Market Attractiveness Index, By Functionality
8.2. Immunity Booster*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Cardiovascular Health
8.4. Others

9. By Application

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.1.2. Market Attractiveness Index, By Application
9.2. Food and Beverages*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Supplements
9.4. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. U.S.
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. UK
  - 10.3.6.3. France
  - 10.3.6.4. Italy
  - 10.3.6.5. Spain
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan
  - 10.5.6.4. Australia
  - 10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. KANEHIDE BIO Co., Ltd.*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Kamerycah, Inc.
12.3. Yaizu Suisankagaku
12.4. Fucoidan Force
12.5. Seaherb
12.6. Haerim Fucoidan
12.7. Marinova
12.8. Hi-Q Marine Biotech International Ltd.
12.9. Molekula Group
12.10. Absonutrix LLC LIST NOT EXHAUSTIVE

13. Appendix

13.1. About Us and Services
13.2. Contact Us

02-2729-4219

+886-2-2729-4219

License/价格

全球褐藻醣胶市场 - 2023-2030

Global Fucoidan Market - 2023-2030

概述 ：

动态：

不断努力改进微藻萃取和培养

全球心血管疾病和癌症病例正在增加

生产成本高

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动力学

第 5 章：产业分析

第 6 章：COVID-19 分析

第 7 章：按类型

第 8 章：依功能分类

第 9 章：按应用

第 10 章：按地区

第 11 章：竞争格局

第 12 章：公司简介

第 13 章：附录

Overview: